## Abstract The Inhibitor of Growth 1 (ING1) gene has been identified and characterized as a Type‐II tumor suppressor gene (TSG). Subsequently, 4 additional members of the family were identified by homology search. ING proteins contain a nuclear localization sequence (NLS) and a plant homeo domain
The ARF tumor suppressor: Structure, functions and status in cancer
✍ Scribed by Peggy Ozenne; Beatrice Eymin; Elisabeth Brambilla; Sylvie Gazzeri
- Book ID
- 102275649
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 209 KB
- Volume
- 127
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The INK4b‐ARF‐INK4a locus encodes two members of the INK4 family of cyclin‐dependent kinase inhibitors, p15^INK4b^ and p16^INK4a^, and a completely unrelated protein called ARF. ARF is a nucleolar protein with unusual structure that exhibits tumor suppressive functions. There is growing evidence that ARF signaling is complex, and involves p53‐dependent or ‐independent pathways aiming mainly at restraining abnormal cell growth and at maintaining genomic stability. As such, ARF is a critical component of tumor surveillance, and its expression is decreased in human tumors. In this review, we present the current knowledge on ARF regulation and major functions. The ARF status in human tumors is also briefly summarized.
📜 SIMILAR VOLUMES
## Abstract We describe a mechanism for reversible regulation of gene transcription, mediated by a family of tumor‐suppressor proteins (TSP) containing a DNA‐binding domain (DBD) that binds to a gene and represses transcription, and RNA‐binding domains (RBDs) that bind RNA, usually a noncoding RNA
## Abstract Mel‐18 is a member of the polycomb group (PcG) proteins, which are chromatin regulatory factors and play important roles in development and oncogenesis. This study was designed to investigate the clinical and prognostic significance of Mel‐18 in patients with prostate cancer. A total of
## Abstract Secreted frizzled‐related protein‐5 (__sFRP‐5__) has been identified as 1 of the secreted antagonists that bind Wnt protein. However, the functional significance of __sFRP‐5__ in renal cell cancer (RCC) has not been reported. We hypothesized that __sFRP‐5__ may be epigenetically downreg